265 related articles for article (PubMed ID: 9284854)
1. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
[TBL] [Abstract][Full Text] [Related]
2. Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period.
Lee BS; Byun SY; Chung ML; Chang JY; Kim HY; Kim EA; Kim KS; Pi SY
Neonatology; 2010; 98(2):191-9. PubMed ID: 20234144
[TBL] [Abstract][Full Text] [Related]
3. Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
Andriessen P; Struis NC; Niemarkt H; Oetomo SB; Tanke RB; Van Overmeire B
Acta Paediatr; 2009 May; 98(5):797-803. PubMed ID: 19187396
[TBL] [Abstract][Full Text] [Related]
4. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
Chotigeat U; Jirapapa K; Layangkool T
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
[TBL] [Abstract][Full Text] [Related]
5. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
[TBL] [Abstract][Full Text] [Related]
7. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
Leonhardt A; Strehl R; Barth H; Seyberth HW
Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
[TBL] [Abstract][Full Text] [Related]
8. The use of dopamine for the prevention of the renal side effects of indomethacin in premature infants with patent ductus arteriosus.
Seri I; Tulassay T; Kiszel J; Csömör S
Int J Pediatr Nephrol; 1984 Dec; 5(4):209-14. PubMed ID: 6397454
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
[TBL] [Abstract][Full Text] [Related]
10. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
Supapannachart S; Limrungsikul A; Khowsathit P
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
[TBL] [Abstract][Full Text] [Related]
11. [Renal effects of prolonged indomethacin therapy in premature infants].
Gouyon JB; Chouchane M; Françoise M
Arch Pediatr; 1994 Oct; 1(10):894-7. PubMed ID: 7842069
[TBL] [Abstract][Full Text] [Related]
12. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
Yeh TF; Wilks A; Singh J; Betkerur M; Lilien L; Pildes RS
J Pediatr; 1982 Sep; 101(3):433-7. PubMed ID: 7108667
[TBL] [Abstract][Full Text] [Related]
13. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
Brion LP; Campbell DE
Cochrane Database Syst Rev; 2001; (3):CD001148. PubMed ID: 11686979
[TBL] [Abstract][Full Text] [Related]
14. Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.
Brion LP; Campbell DE
Cochrane Database Syst Rev; 2000; 2001(2):CD001148. PubMed ID: 10796253
[TBL] [Abstract][Full Text] [Related]
15. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
[TBL] [Abstract][Full Text] [Related]
16. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
[TBL] [Abstract][Full Text] [Related]
17. Can dopamine prevent the renal side effects of indomethacin? A prospective randomized clinical study.
Baenziger O; Waldvogel K; Ghelfi D; Arbenz U; Fanconi S
Klin Padiatr; 1999; 211(6):438-41. PubMed ID: 10592922
[TBL] [Abstract][Full Text] [Related]
18. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome.
Van Overmeire B; Van de Broek H; Van Laer P; Weyler J; Vanhaesebrouck P
J Pediatr; 2001 Feb; 138(2):205-11. PubMed ID: 11174617
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
Supapannachart S; Khowsathit P; Patchakapati B
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
